Clinical trial Recruiting at 2 sites Interventional Ages 75 and up

Gallbladder removal versus watchful waiting after bile duct stone removal in older adults

Official title: ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

Run by Helsinki University Central Hospital · NCT07001423 · Data updated 2026-11-12

This trial tests whether immediate laparoscopic gallbladder removal or a wait-and-see approach is better for older patients after their common bile duct stones have been removed by ERCP.

More Choledocholithiasis trials

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment400 (estimated)
SponsorHelsinki University Central Hospital
Academic / other
Locations12 sites (Espoo and 11 other locations)
StatusRecruiting
StartedOctober 9, 2025
Main results expectedAugust 31, 2031
Study endsAugust 31, 2032
Registry record updatedSeptember 16, 2026
Trial IDNCT07001423 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults (age ≥80, or 75–79 with a Charlson Comorbidity Index ≥2) who have had common bile duct stones cleared by ERCP and still have their gallbladder, and who can give informed consent.

Probably not a fit

Patients with acute cholecystitis, recent biliary pancreatitis or severe post-ERCP pancreatitis, chronic pancreatitis, bile duct pathology, widespread malignancy, or those unable to consent are not likely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial enrolls elderly patients whose common bile duct stones were successfully cleared by ERCP and randomizes 400 participants 1:1 to either laparoscopic cholecystectomy (done during the same admission or within two weeks) or a wait-and-see policy. The primary outcome is a composite of death, major postoperative complications, or recurrent biliary disease within one year after randomization. One planned interim safety analysis will be performed after 100 patients, with a strict stopping rule if a clear difference emerges (p<0.001). Eligible patients are generally aged ≥80, or 75–79 with higher comorbidity, and must have the gallbladder in place without active cholecystitis or significant pancreatitis.

Why it matters

Potential benefit: If successful, this could spare many older patients from an unnecessary operation while keeping rates of death, major complications, and recurrent biliary problems low.

How similar studies have gone: Previous smaller trials and observational studies have had mixed results, with some suggesting conservative management can be safe in selected elderly patients, but randomized evidence in this specific high-risk elderly group is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP)
* Age \>= 80 years or age 75-79 years with a Charlson Comorbidity index \>=2
* gallbladder in situ

Exclusion Criteria:

* Acute Cholecystitis
* Biliary Pancreatitis
* Severe or moderately severe post-ERCP pancreatitis
* Chronic pancreatitis
* Bile duct pathology
* Widespread malignancy
* Unable to give consent

Where it's running

  • Helsinki University Hospital, Jorvi
    Espoo, Finland
    Recruiting
  • Helsinki University Hospital, Meilahti
    Helsinki, Finland
    Recruiting
  • Kanta-Häme Central Hospital
    Hämeenlinna, Finland
    Not yet recruiting
  • Pohjois-Karjala Central Hospital
    Joensuu, Finland
    Not yet recruiting
  • Keski-Suomi Central Hospital
    Jyväskylä, Finland
    Not yet recruiting
  • Kymenlaakso Central Hospital
    Kotka, Finland
    Not yet recruiting
Show 6 more locations
  • Kuopio University Hospital
    Kuopio, Finland
    Not yet recruiting
  • Päijät-Häme Central Hospital
    Lahti, Finland
    Not yet recruiting
  • Oulu University Hospital
    Oulu, Finland
    Not yet recruiting
  • Tampere University Hospital
    Tampere, Finland
    Not yet recruiting
  • Turku University Hospital
    Turku, Finland
    Not yet recruiting
  • Vaasa Central Hospital
    Vaasa, Finland
    Not yet recruiting

Study contacts

  • Principal investigator: Panu Mentula, MD, PhD — Helsinki University Central Hospital
  • Study coordinator: Panu Mentula, MD, PhD
  • Email: panu.mentula@hus.fi
  • Phone: +358504270183

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.